Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BI 836880 |
Trade Name | |
Synonyms | BI836880|BI-836880|Bi-specific Anti-VEGF/Ang2 Nanobody BI 836880 |
Drug Descriptions |
BI 836880 is a nanobody that binds to both VEGF and ANGPT2, which inhibits downstream signaling, potentially resulting in antitumor activity (PMID: 37140602). |
DrugClasses | VEGF Antibody 12 |
CAS Registry Number | 2254603-60-4 |
NCIT ID | C126644 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BI 836880 | BI 836880 | 0 | 0 |
BI 836880 + Effi-DEM + Ezabenlimab | BI 836880 Effi-DEM Ezabenlimab | 0 | 1 |
BI 836880 + Ezabenlimab | BI 836880 Ezabenlimab | 0 | 1 |